Medicine, Nursing and Health Sciences Contact us ASPREE ... · School of Public Health and Preventive Medicine ... the onset of dementia and certain cancers, ... and benefits of aspirin
Post on 12-May-2018
217 Views
Preview:
Transcript
www.monash.edu
ASPREE
Medicine, Nursing and Health Sciences
School of Public Health and Preventive Medicine
The information in this brochure was correct at the time of publication – August 2011. Monash University reserves the right to alter this information should the need arise.
You should always check with the institution when considering a course. CRICOS provider: Monash University 00008C. MMS326158
Contact usTo contact ASPREE: Tel: 1800 728 745 Email: aspree@monash.edu
To contact School of Preventive Health and Preventive Medicine:
Dr Jay Illesinghe Research Administrative Manager
Tel: + 61 03 9903 0929 Fax: + 61 03 9903 0556 Email: Jayamini.Illesinghe@ monash.edu
FundingNIH $50 million US
NHMRC $3.5 million
CSIRO $3.4 million
Victorian Cancer Agency $2 million
Bayer HealthCare is providing the study medication
Primary Ethics ApprovalsRoyal Australian College of General Practitioners
Monash University
www.aspree.org
facebook.com/Monash.University
twitter.com/Monash_FMNHS
Benefits to the Health of AustraliansContribution to medical knowledge about prevention
Increasing capacity to attract similar clinical trials
Training new clinical and public health researchers
Adding value to biomedical research (Biobank)
Improved understanding of health and ageing
Bringing clinical research to regional centres
ASPREE
ASPREE (ASPirin in Reducing Events in the Elderly) will determine if daily low-dose aspirin can delay or prevent a heart attack or stroke, the onset of dementia and certain cancers, such as bowel cancer. It will, for the first time, analyse the risks and benefits of aspirin therapy in healthy older people.
The Trial � Double blind randomised
� 19,000 participants, 12,500 in Australia 6,500 in the USA
� Aged 70 plus, healthy
� Five years follow up
� Half receive aspirin, half placebo
� Collaboration with Australian general practitioners
� ASPREE is the largest primary prevention trial ever undertaken in Australia
Collaborators � Monash University (Australian lead)
� Berman Center, Minnesota (USA lead)
� CSIRO
� University of Melbourne
� University of Tasmania
� Australian National University
Add-on StudiesASPREE Biobank: blood samples on commencement
Purpose: better prediction,earlier treatment of serious disease
ASPREE-ALSOP: questionnaires completed during study
Purpose: improved understanding of the problems of ageing including: mobility, hearing, eyesight, dental care, diet, exercise
Benefits to the Health of AustraliansContribution to medical knowledge about prevention
Increasing capacity to attract similar clinical trials
Training new clinical and public health researchers
Adding value to biomedical research (Biobank)
Improved understanding of health and ageing
Bringing clinical research to regional centres
ASPREE
ASPREE (ASPirin in Reducing Events in the Elderly) will determine if daily low-dose aspirin can delay or prevent a heart attack or stroke, the onset of dementia and certain cancers, such as bowel cancer. It will, for the first time, analyse the risks and benefits of aspirin therapy in healthy older people.
The Trial � Double blind randomised
� 19,000 participants, 12,500 in Australia 6,500 in the USA
� Aged 70 plus, healthy
� Five years follow up
� Half receive aspirin, half placebo
� Collaboration with Australian general practitioners
� ASPREE is the largest primary prevention trial ever undertaken in Australia
Collaborators � Monash University (Australian lead)
� Berman Center, Minnesota (USA lead)
� CSIRO
� University of Melbourne
� University of Tasmania
� Australian National University
Add-on StudiesASPREE Biobank: blood samples on commencement
Purpose: better prediction,earlier treatment of serious disease
ASPREE-ALSOP: questionnaires completed during study
Purpose: improved understanding of the problems of ageing including: mobility, hearing, eyesight, dental care, diet, exercise
www.monash.edu
ASPREE
Medicine, Nursing and Health Sciences
School of Public Health and Preventive Medicine
The information in this brochure was correct at the time of publication – August 2011. Monash University reserves the right to alter this information should the need arise.
You should always check with the institution when considering a course. CRICOS provider: Monash University 00008C. MMS326158
Contact usTo contact ASPREE: Tel: 1800 728 745 Email: aspree@monash.edu
To contact School of Preventive Health and Preventive Medicine:
Dr Jay Illesinghe Research Administrative Manager
Tel: + 61 03 9903 0929 Fax: + 61 03 9903 0556 Email: Jayamini.Illesinghe@ monash.edu
FundingNIH $50 million US
NHMRC $3.5 million
CSIRO $3.4 million
Victorian Cancer Agency $2 million
Bayer HealthCare is providing the study medication
Primary Ethics ApprovalsRoyal Australian College of General Practitioners
Monash University
www.aspree.org
facebook.com/Monash.University
twitter.com/Monash_FMNHS
top related